β blockers, atrial fibrillation, and heart failure

Affiliations

¹ British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8QQ, Scotland, UK. Electronic address: john.mcmurray@glasgow.ac.uk.
² Department of Cardiology, University of Groningen and University Medical Center Groningen, Groningen, Netherlands.

Comment

John J V McMurray et al. Lancet. 2014.

. 2014 Dec 20;384(9961):2181-3.

doi: 10.1016/S0140-6736(14)62340-0. Epub 2014 Dec 19.

¹ British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8QQ, Scotland, UK. Electronic address: john.mcmurray@glasgow.ac.uk.
² Department of Cardiology, University of Groningen and University Medical Center Groningen, Groningen, Netherlands.

No abstract available

Comment on

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis.
Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG, Lip GY, Coats AJ, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD; Beta-Blockers in Heart Failure Collaborative Group. Kotecha D, et al. Lancet. 2014 Dec 20;384(9961):2235-43. doi: 10.1016/S0140-6736(14)61373-8. Epub 2014 Sep 2. Lancet. 2014. PMID: 25193873